Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fresh vs. Frozen FMT for Recurrent CDI
NCT01398969Phase 2Completed
- Sponsor
- McMaster University
- Start
- Jul 2012
- Primary completion
- Jan 2015
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of allogeneic fecal microbiota in Clostridium difficile infection (CDI), sponsored by McMaster University. Primary endpoint: Evaluation of the safety of HBT at 13 weeks. Started Jul 2012; status: completed.
02
Drugs
allogeneic fecal microbiota
03
Conditions
Clostridium difficile infection (CDI)
Beyond the preview
Go deeper on NCT01398969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01398969.